BioLineRx Ltd share price logo

BioLineRx Ltd Share Price

NASDAQ: BLRX

Small Cap

$2.36

+0.09

(+3.96%)

Live

as on

BioLineRx Ltd Stock Performance

as on April 28, 2026 at 2:09 am IST

  • Day's Low

    Day's High

    $2.30
    $2.39
    downward going graph

    2.54%

    Downside

    1.27%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.15
    $7.77
    downward going graph

    8.90%

    Downside

    229.23%

    Upside

    downward going graph

BioLineRx Ltd share price movements today

Previous Close
$2.27
Open
$2.30
Volume
24.9K
Day's Low - High
$2.30 - $2.39
52 Week Low - High
$2.15 - $7.77

BioLineRx Ltd Historical Returns

1 Month Return
-4.22 %
3 Month Return
-25.57 %
1 Year Return
-29.5 %
3 Year Return
-94.72 %
5 Year Return
-98.15 %

BioLineRx Ltd Stock Fundamentals & Key Indicators

Check BioLineRx Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.2M

EPS (TTM)

-1.09

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.2

Return On Equity TTM

-11.01%

BioLineRx Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioLineRx Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$10.2M-98.15%NA-99.58%
BUY$40.8B116.23%131.78.45%
BUY$109.5B99.64%28.132.94%
NA$33.4BNA121.785.37%
BUY$79.5B52.82%18.1131.41%

Stock Returns calculator for BioLineRx Ltd Stock including INR - Dollar returns

The BioLineRx Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

BioLineRx Ltd investment value today

Current value as on today

₹81,061

Returns

-₹18,939

(-18.94%)

Returns from BioLineRx Ltd Stock

-₹26,708 (-26.71%)

Dollar Impact

₹7,769 (+7.77%)

BioLineRx Ltd Stock’s Investor Sentiment and Interest

Search interest for BioLineRx Ltd Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:34% versus previous 30 day period

BioLineRx Ltd Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
4
6
5
4
11
0
0
0
0
Gross Profit
0
1
5
4
4
5
0
0
0
0
Operating Income
-12
-18
-4
-5
-5
-4
-2
-2
-2
-3
EBITDA
-14
-14
1
3
-3
3
5
-3
0
-3
Interest Expense
0
0
0
2
1
4
0
0
0
0
Depreciation
0
0
0
0
0
1
0
0
0
0
Income Before Tax
-16
-13
0
0
-5
-3
5
-3
0
-2
Income Tax Expense
-2
-4
5
-
-
-
-
-
-
-
Net Income
-16
-13
0
0
-5
-3
5
-3
0
-1
Net Profit Margin
0.00%
-289.25%
-10.15%
8.97%
-117.78%
-27.13%
2010.59%
-1296.05%
-228.81%
-713.92%

BioLineRx Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
4
28
1
Gross Profit
0
0
0
0
0
0
0
1
19
0
Operating Income
-16
-25
-25
-28
-22
-24
-29
-49
-20
-10
EBITDA
-15
-24
-22
-22
-27
-24
-28
-57
3
-9
Interest Expense
0
0
0
1
1
0
2
2
9
1
Depreciation
-
0
0
0
0
0
0
1
4
0
Income Before Tax
-15
-24
-22
-25
-30
-27
-24
-60
-9
-2
Income Tax Expense
0
0
2
1
0
1
-4
0
-
-
Net Income
-15
-24
-22
-25
-30
-27
-24
-60
-9
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-1262.79%
-31.86%
-99.58%

BioLineRx Ltd Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-13
0
0
-5
-3
5
-3
0
-1
Operating Cash Flow
4
-14
-11
-9
-8
-2
0
-2
-3
Investing Cash Flow
-20
16
-8
10
11
-8
-3
3
0
Financing Cash Flow
11
0
23
-1
-1
9
1
0
-1
Change in Cash
-3
1
3
0
1
-1
-1
0
-4

BioLineRx Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-22
-25
-30
-27
-24
-60
-9
-1
Operating Cash Flow
-20
-24
-22
-23
-23
-26
-22
-43
-8
Investing Cash Flow
-15
9
5
16
-38
4
1
29
-8
Financing Cash Flow
38
13
19
17
57
20
15
20
8
Change in Cash
2
-1
1
11
-3
-2
-6
6
-7

Global Institutional Holdings in BioLineRx Ltd

Funds
Holdings
Tower Research Capital LLC
0%
CapTrust Financial Advisors
0%
Morgan Stanley - Brokerage Accounts
0.14%
Citadel Advisors Llc
0.84%
Values First Advisors Inc
0%

Insights on BioLineRx Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 24.7% return, outperforming this stock by 54.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, BioLine RX Ltd has experienced a drawdown of -94.7%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 89.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, BLRX stock has moved down by -94.7%

About BioLineRx Ltd

BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
OrganisationBioLineRx Ltd
HeadquartersModi?in Technology Park, Hevel Modi'in, Israel, 7177871
IndustryBiotechnology
CEOMr. Philip A. Serlin CPA, M.B.A.
E-voting on sharesClick here to vote

Key Management of BioLineRx Ltd

Name

Title

Mr. Philip A. Serlin CPA, M.B.A.

Chief Executive Officer

Ms. Mali Zeevi CPA

Chief Financial Officer

Dr. Ella Sorani Ph.D.

Chief Development Officer

Mr. John Lacey

Head of Corporate Communications & Investor Relations

Mr. Raziel Fried

Treasurer & Budgetary Control Director

FAQs

What is BioLineRx Ltd share price today?

BioLineRx Ltd share price today is $2.36 as on . BioLineRx Ltd share today touched a day high of $2.39 and a low of $2.3.

What is the 52 week high and 52 week low for BioLineRx Ltd share?

BioLineRx Ltd share touched a 52 week high of $7.77 on and a 52 week low of $2.15 on . BioLineRx Ltd stock price today i.e. is trending at $2.36,which is 69.63% down from its 52 week high and 9.77% up from its 52 week low.

What is BioLineRx Ltd's market capitalisation today?

BioLineRx Ltd market capitalisation is $0.00T as on .

How to invest in BioLineRx Ltd Stock (BLRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioLineRx Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioLineRx Ltd Shares that will get you 0.6356 shares as per BioLineRx Ltd share price of $2.36 per share as on April 27, 2026 at 8:39 pm IST.

What is the minimum amount required to buy BioLineRx Ltd Stock (BLRX) from India?

Indian investors can start investing in BioLineRx Ltd (BLRX) shares with as little as ₹94.19 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹941.90 in BioLineRx Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on BioLineRx Ltd share’s latest price of $2.36 as on April 27, 2026 at 8:39 pm IST, you will get 4.2373 shares of BioLineRx Ltd. Learn more about fractional shares .

What are the returns that BioLineRx Ltd has given to Indian investors in the last 5 years?

BioLineRx Ltd stock has given -98.15% share price returns and 26.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?